Manulife (Manufacturers Life Insurance)’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,311	Closed	-$182K	–	4118
2018 Q2	$182K	Buy	+9,311	New	+$174K	﹤0.01%	3195
2017 Q2	–	Sell	-10,322	Closed	-$122K	–	4498
2017 Q1	$122K	Buy	10,322 +912	+10%	+$11.1K	﹤0.01%	3105
2016 Q4	$123K	Buy	9,410 +675	+8%	+$9.04K	﹤0.01%	3126
2016 Q3	$126K	Sell	8,735 -253	-3%	-$3.59K	﹤0.01%	3095
2016 Q2	$108K	Buy	8,988 +2,455	+38%	+$39.4K	﹤0.01%	3186
2016 Q1	$119K	Buy	6,533 +3	+0%	+$50	﹤0.01%	2955
2015 Q4	$141	Hold	6,530	–	–	﹤0.01%	2911
2015 Q3	$110	Buy	6,530 +186	+3%	+$4.63K	﹤0.01%	3081
2015 Q2	$238	Buy	+6,344	New	+$205K	﹤0.01%	2719

Other funds holding CBMG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CBMG Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q3 2018, closing a stake of 9,311 shares — an estimated $182K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CBMG in Q2 2015 and held it in 9 quarters. The position peaked at $182K in Q2 2018. 38 funds tracked by Wall St. Rank hold CBMG as of Q3 2018.

Manulife (Manufacturers Life Insurance) reported no remaining Cellular Biomedicine Group, Inc. position as of Q3 2018 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 9,311 Cellular Biomedicine Group, Inc. shares in Q3 2018, an estimated $182K.
Manulife (Manufacturers Life Insurance) first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 9 quarters.
Manulife (Manufacturers Life Insurance)'s Cellular Biomedicine Group, Inc. position peaked at $182K in Q2 2018.
38 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.